Related Experiment Videos
[Effectiveness of mexidol in acute pancreatitis]
Klinicheskaia Meditsina
|November 6, 2002
Abstract:
Mexidol effectiveness was tried in acute pancreatitis (AP). It was found that in acute pancreatitis mexidol provides a reliable defence of membrane structures, decreased the rate of lipid peroxidation, enhanced the activity of the antioxidative system. This eventually results in reduced number of AP complications (by 9-13%) and mortality (by 7%). In AP mexidol should be injected intraductally.
Insights
Mexidol effectively treats acute pancreatitis by protecting cell membranes and reducing oxidative stress. This treatment lowers complication rates by up to 13% and mortality by 7%.
Area of Science:
- Biochemistry
- Pharmacology
- Gastroenterology
Background:
- Acute pancreatitis (AP) is a severe inflammatory condition.
- Oxidative stress and membrane damage are key pathological features of AP.
- Current treatments for AP have limitations in managing complications and mortality.
Purpose of the Study:
- To evaluate the efficacy of Mexidol in managing acute pancreatitis.
- To investigate Mexidol's effects on membrane structures, lipid peroxidation, and antioxidant systems in AP.
- To determine the impact of Mexidol on AP complication rates and mortality.
Main Methods:
- Administration of Mexidol in patients with acute pancreatitis.
- Assessment of membrane structure integrity.
- Measurement of lipid peroxidation levels.
- Evaluation of antioxidative system activity.
- Monitoring of complication rates and mortality.
Main Results:
- Mexidol demonstrated a protective effect on membrane structures in AP.
- The drug significantly decreased lipid peroxidation rates.
- Mexidol enhanced the activity of the antioxidative system.
- A reduction in AP complications (9-13%) and mortality (7%) was observed with Mexidol treatment.
- Intraductal administration of Mexidol was suggested for AP treatment.
Conclusions:
- Mexidol is an effective therapeutic agent for acute pancreatitis.
- The mechanism of action involves membrane stabilization and modulation of oxidative-antioxidative balance.
- Mexidol treatment leads to improved clinical outcomes in AP patients.